| Product Code: ETC6652146 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada COVID-19 Infection Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada COVID-19 Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Canada COVID-19 Infection Market - Industry Life Cycle |
3.4 Canada COVID-19 Infection Market - Porter's Five Forces |
3.5 Canada COVID-19 Infection Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada COVID-19 Infection Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Canada COVID-19 Infection Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Canada COVID-19 Infection Market Revenues & Volume Share, By Dosage Forms, 2021 & 2031F |
3.9 Canada COVID-19 Infection Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Canada COVID-19 Infection Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Canada COVID-19 Infection Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada COVID-19 Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in the number of confirmed COVID-19 cases in Canada |
4.2.2 Government initiatives and policies related to testing, tracing, and vaccination |
4.2.3 Public awareness and adherence to safety measures |
4.3 Market Restraints |
4.3.1 Emergence of new COVID-19 variants |
4.3.2 Supply chain disruptions affecting availability of testing kits and medical supplies |
4.3.3 Vaccine hesitancy among the population |
5 Canada COVID-19 Infection Market Trends |
6 Canada COVID-19 Infection Market, By Types |
6.1 Canada COVID-19 Infection Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada COVID-19 Infection Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada COVID-19 Infection Market Revenues & Volume, By Omicron, 2021- 2031F |
6.1.4 Canada COVID-19 Infection Market Revenues & Volume, By Delta, 2021- 2031F |
6.1.5 Canada COVID-19 Infection Market Revenues & Volume, By Gamma, 2021- 2031F |
6.1.6 Canada COVID-19 Infection Market Revenues & Volume, By Beta, 2021- 2031F |
6.1.7 Canada COVID-19 Infection Market Revenues & Volume, By Alpha, 2021- 2031F |
6.2 Canada COVID-19 Infection Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Canada COVID-19 Infection Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Canada COVID-19 Infection Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.4 Canada COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada COVID-19 Infection Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Canada COVID-19 Infection Market Revenues & Volume, By Swab Test, 2021- 2031F |
6.3.3 Canada COVID-19 Infection Market Revenues & Volume, By Antibody Test, 2021- 2031F |
6.3.4 Canada COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada COVID-19 Infection Market, By Dosage Forms |
6.4.1 Overview and Analysis |
6.4.2 Canada COVID-19 Infection Market Revenues & Volume, By Capsule, 2021- 2031F |
6.4.3 Canada COVID-19 Infection Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.4 Canada COVID-19 Infection Market Revenues & Volume, By Injections, 2021- 2031F |
6.4.5 Canada COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Canada COVID-19 Infection Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Canada COVID-19 Infection Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Canada COVID-19 Infection Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Canada COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada COVID-19 Infection Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Canada COVID-19 Infection Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Canada COVID-19 Infection Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Canada COVID-19 Infection Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Canada COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Canada COVID-19 Infection Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Canada COVID-19 Infection Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Canada COVID-19 Infection Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Canada COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Canada COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada COVID-19 Infection Market Import-Export Trade Statistics |
7.1 Canada COVID-19 Infection Market Export to Major Countries |
7.2 Canada COVID-19 Infection Market Imports from Major Countries |
8 Canada COVID-19 Infection Market Key Performance Indicators |
8.1 Percentage of population vaccinated |
8.2 Daily new confirmed cases |
8.3 Test positivity rate |
8.4 Hospitalization and ICU occupancy rates |
8.5 Public compliance with mask-wearing and social distancing regulations |
9 Canada COVID-19 Infection Market - Opportunity Assessment |
9.1 Canada COVID-19 Infection Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada COVID-19 Infection Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Canada COVID-19 Infection Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Canada COVID-19 Infection Market Opportunity Assessment, By Dosage Forms, 2021 & 2031F |
9.5 Canada COVID-19 Infection Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Canada COVID-19 Infection Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Canada COVID-19 Infection Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada COVID-19 Infection Market - Competitive Landscape |
10.1 Canada COVID-19 Infection Market Revenue Share, By Companies, 2024 |
10.2 Canada COVID-19 Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here